Factor has launched the new One aero race bike, claimed to be the “fastest UCI-legal road bike in the world”. Formerly known as the ‘Prototype’, which made its racing debut under select Israel–Premier ...

"Fear Factor" is returning to screens, and it’s looking very different from the last time you saw it. Officially called "Fear Factor: The Next Chapter", the extreme competition series is adding a ...

CDC and Florida Health Department researchers found seven risk factors that can lead to clinical Candida auris cases. The study, published Oct. 2 in Clinical Infectious Diseases, analyzed patients in ...

Factor investing targets securities with traits historically linked to superior risk-adjusted returns. Diversification within asset classes, based on factors like size or momentum, curtails portfolio ...

The pathogenicity of Cryptococcus neoformans is heterogeneous and is associated with the expression of virulence factors. This study aimed to correlate the pathogenicity of C. neoformans var. grubii ...

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, public reviews, and a provisional response from the authors. In the manuscript ...

This is an important study that connects the polymerase-associated factor 1 complex (Paf1C) with Histone 2B monoubiquitination and the expression of genes key to virulence in Cryptococcus neoformans.

Five risk factors account for approximately 50% of the global burden of cardiovascular disease. How the presence or absence of classic risk factors affects lifetime estimates of cardiovascular disease ...

More than ever, companies need leaders who are good with people. by Raffaella Sadun, Joseph Fuller, Stephen Hansen and PJ Neal For a long time, whenever companies wanted to hire a CEO or another key ...

Below is Validea's guru fundamental report for CITIGROUP INC (C). Of the 22 guru strategies we follow, C rates highest using our Multi-Factor Investor model based on the published strategy of Pim van ...

A lab has completed a six-year study to examine the virulence of 38 clinical isolates from various strains of Cryptococcus. Ultimately, the goal is to find ways to stop deadly disease caused by ...